---
title: "Melanoma tumour thickness in Norway"
subtitle: "An analysis of survival trend,<br>1983â€“2019"
author: "Raju Rimal"
date: "13 June, 2023"
institute: "Department of Biostatistics<br>University of Oslo"
code-overflow: scroll
date-format: "DD MMMM YYYY"
bibliography: References.bib
citations-hover: true
knitr:
  opts_chunk: 
    collapse: true
    comment: "#>" 
execute: 
  echo: false
  warning: false
format: 
  revealjs:
    transition: slide
    background-transition: concave
    template-partials:
      - title-slide.html
    theme: [default, custom.scss]
    logo: Images/Logos/UiO-Logo.png
    title-slide-attributes:
      data-background-color: "#FCFCFC"
      data-background-image: Images/melo.svg
      data-background-opacity: "0.75"
      data-background-size: auto 80%
      data-background-position: 90% center
editor_options: 
  chunk_output_type: console
nocite: "@*"
---

```{r}
#| include: false

library(data.table)
library(ggplot2)
library(stringr)
library(purrr)
library(ggh4x)
library(gt)

ggplot2::theme_set(ggthemes::theme_few())
theme_update(panel.grid = element_line(color = "#f0f0f0"))

# Color schemes (uchicago):
#   Default: default_uchicago:
#     #800000 #767676 #FFA319 #8A9045 #155F83 
#     #C16622 #8F3931 #58593F #350E20
#   Dark: dark_uchicago:
#     #800000 #767676 #CC8214 #616530 #0F425C 
#     #9A5324 #642822 #3E3E23 #350E20 
#   Light: light_uchicago:
#     #800000 #D6D6CE #FFB547 #ADB17D #5B8FA8 
#     #D49464 #B1746F #8A8B79 #725663
#   White:
#     #FFFAFA #FCFCFC #FFFDFD #FCFFE0 #F9FCFF 
#     #FFFCFB #FFFAFA #FCFDE5 #FFF8FA
```

## I alone cannot change the world, but I can cast a stone across the waters to create many ripples. {.center .middle visibilty="hidden"}

::: {style="text-align:right; border-right: 2px solid #0F425C; padding-right: 15px; margin-top: 50px; color: #5B8FA8FF;"}
Mother Teresa (1910--1997)
:::

::: {style="text-align:right; border-right: 2px solid gray; padding-right: 15px; font-size: 80%; color: #767676; display: block;"}
Social worker, Nurse
:::


## Research Interest {.ai .dark .columns background-image="Images/AI/Melanoma-Cell-1.jpg" background-position="right" background-size="auto 100%" visibilty="hidden"}

::: {.column width="50%"}
::: {.callout-important appearance="simple" icon="false"}
-   Cutaneous melanoma (CM) is the _most aggressive_ and _lethal_ form of skin cancer.
:::

::: {.callout-warning appearance="simple" icon="false"}
-   Norway is ranked _fifth in incidence_ and _second in mortality_ worldwide.
-   More people _diagnosis with thinner tumour_ and more people _die from thicker tumour_.
:::

::: {.callout-tip appearance="simple" icon="false"}
-   It's _highly curable_ if caught early.
-   _Important role of tumour thickness_ in prognosis.
:::
:::

::: {.column width="50%"}
:::

## Outline {.ai .dark .columns background-image="Images/AI/Steps-Spiral.jpg" background-position="right" background-size="auto 100%"}

::: {.column width="50%"}
-   [Background](#section-1)

-   [Data and Methods](#section-2)

-   [Results](#section-3)

-   [Outlook and Summary](#section-4)
:::

::: {.column width="50%"}
:::

# Research Objective  {.center .middle style="color: #0F425C;"}

To examine ***melanoma survival*** and ***trend*** by tumour thickness in overall and in important subgroups such as *sex* and *age* in a unique nationwide case series over a 35-year time period.

# Background {.center .middle background-color="#767676FF"}

## Data from Cancer Registry of Norway (CRN)

::: {.columns .grid}
::: {.column style="font-size: 120%;"}
::: {.callout-note icon="false" appearance="minimal"}
*Histologically verified* data
:::
::: {.callout-note icon="false" appearance="minimal"}
*Tumour thickness* recorded since 1980 are *now digitized*
:::
::: {.callout-note icon="false" appearance="minimal"}
*Melanoma registry* established in 2008 under CRN provides the data
:::
::: {.callout-tip icon="false" appearance="minimal"}
Here we will use data from *1983 to 2019*
:::
:::

::: {.column}
![](Images/Logos/CRN-Logo-NoText.svg){fig-align="right"}
:::
:::

## Melanoma and tumour thickness 

### T-categories

![Source: `https://www.cancerresearchuk.org/about-cancer/melanoma/stages-types/tnm-staging`](Images/T-Stages.svg){width="100%" fig-align="center"}

<!--
::: {.absolute .fragment .fade-in-then-out .fade-out data-id="box1" style="border: 2px solid #800000; width: 130px; height: 90px; margin: 10px; background: #80000011; border-radius: 10%;" top="18%" left="30%"}
:::

::: {.absolute .fragment .fade-right .fade-in-then-out data-id="box1" style="border: 2px solid #800000; width: 130px; height: 90px; margin: 10px; background: #80000022; border-radius: 10%;" top="18%" left="42%"}
:::

::: {.absolute .fragment .fade-right .fade-in-then-out data-id="box1" style="border: 2px solid #800000; width: 130px; height: 90px; margin: 10px; background: #80000033; border-radius: 10%;" top="18%" left="57%"}
:::

::: {.absolute .fragment .fade-right .fade-in-then-out data-id="box1" style="border: 2px solid #800000; width: 130px; height: 90px; margin: 10px; background: #80000044; border-radius: 10%;" top="18%" left="70%"}
:::
-->

#  {.center .middle background-color="#155F83FF"}

::: {.r-fit-text}
Data & Methods
:::

## Basic characteristics of data {background-transition="none" transition="none" background-image="Images/Characteristics-Age.PNG" background-size="90% auto" background-position="center 80%"}

::: {.callout-note icon="false"}
### Age at diagnosis

Age at diagnosis has increased in the recent period than earlier.
:::

## Basic characteristics of data {background-transition="none" transition="none" background-image="Images/Characteristics-Thickness.PNG" background-size="90% auto" background-position="center 80%"}

::: {.callout-note icon="false"}
### Tumour thickness

The thickness of tumour at diagnosis has decreased in the recent period than earlier.
:::


## Methods {.top}

```{r}
methods <- data.table(
  "Method" = c(
    "[Relative survival](#relative-survival)", 
    "[Cumulative incidence](#cumulative-incidence)",
    "[Conditional relative survival](#conditional-relative-survival)",
    "[Trend in relative survival](#relative-survival-trend)"
  ),
  "Description" = c(
    paste(
      "A way of _comparing the survival_ of people who have",
      "melanoma with those who don't, over a certain period of time."
    ),
    paste(
      "The proportion of a population at risk that develops melanoma",
      "over a specified time period. The _percentage of individuals",
      "died from melanoma_ over a specific time period."
    ),
    paste(
      "Relative survival of a melanoma patients surviving a certain",
      "number of year (y) _given that the patients has already",
      "survived_ a fixed number of years (x) since diagnosis."
    ),
    paste(
      "_Changes in relative survival_ over a certain period."
    )
  )
)
print_gt <- function(data) {
data %>% 
  gt::gt() %>%
  gt::tab_style(
    locations = cells_body(columns = 1, rows = everything()),
    style = cell_text(weight = "bold", align = "right")
  ) %>%
  gt::tab_style(
    locations = cells_column_labels(columns = 1),
    style = cell_text(align = "right")
  ) %>%
  gt::tab_options(
    table.font.size = "1.5rem",
    column_labels.font.weight = "bold",
    table.width = "100%"
  ) %>%
  gt::cols_width(Method ~ "250px") %>%
  gt::fmt_markdown(columns = everything()) %>%
  gt::opt_css(css = "
    .gt_table .gt_row {
      vertical-align: top!important;
    }
    .gt_table tr > :is(th, td) {
      line-height: 2rem;
    }
    .gt_table tr > :is(th, td):nth-child(2) {
      padding-left: 50px!important;
    }
    .gt_table tr > td:nth-child(2) > .gt_from_md > p {
      line-height: 2.2rem;
    }
  ")
}
```

::: {.r-stack}
```{r}
print_gt(methods[1, ])
```

::: fragment
```{r}
print_gt(methods[1:2, ])
```
:::

::: fragment
```{r}
print_gt(methods[1:3, ])
```
:::

::: fragment
```{r}
print_gt(methods[1:4, ])
```
:::

:::

#  {.center .middle background-color="#3E3E23"}

::: r-fit-text
Results
:::

## Relative survival {.smaller}

::: columns
::: {.column width="32%"}

::: {.callout-note appearance="simple" icon="false"}
Patients with thinner melanoma (T1) have similar survival as general population.
:::

::: {.callout-note appearance="simple" icon="false"}
The 5-year survival for patients with T4 melanoma is less than 60%
compared to general population.
:::

::: {.callout-note appearance="simple" icon="false"}
Men have lower survival compared to women in all T-categories.
:::

::: {.callout-note appearance="simple" icon="false"}
Clear difference in survival by T-categories reflects the importants
of tumour thickness in prognosis.
:::

:::
::: {.column width="68%"}
![](plots/surv-by-sex-tstage-ci.svg){width="100%"}
:::
:::

## Relative survival (before & after 2000)

::: columns
::: {.column width="32%"}


::: {.callout-note appearance="simple" icon="false"}
Changes in long-term survival of T1 and T3 melanoma diagnosed from 2000 is larger in men than in women compared to those diagnosed before 2000.
:::

::: {.callout-note appearance="simple" icon="false"}
In T4 melanoma, only small change is observed in men.
:::

:::
::: {.column width="68%"}
![](plots/surv-by-sex-tstage.svg){width="100%"}
:::
:::


## Cumulative incidence {.smaller}

::: columns
::: {.column width="32%"}

::: {.callout-note appearance="simple" icon="false"}
In melanoma patients with T1 tumour, the proportion of dying from melanoma 
is similar to dying from other cause.
:::

::: {.callout-note appearance="simple" icon="false"}
The difference in the proportion of melanoma patients dying from melanoma compared
to dying from other disease grows as tumour thickness increases.
:::

::: {.callout-note appearance="simple" icon="false"}
Men have poor prognosis compared to women (high cumulative incidence).
:::

:::
::: {.column width="68%"}
![](plots/cuminc-by-sex-tstage.svg){width="100%"}
:::
:::

## Is this the effect of treatment?

::: columns

::: {.column width="40%"}

::: {.callout-tip appearance="simple" icon="false"}
Comparing cumulative incidence within distant metastasis cases diagnosed between 2008--2013 and 2014--2019, we observed a drop in melanoma specific deaths in the later period.
:::

::: {.callout-note appearance="simple" icon="false"}
Around year 2014, new treatment immunotherapy was introduced in stage IV melanoma.
:::

:::
::: {.column width="60%"}
![](plots/cuminc-treatment-effect.svg){width="100%"}
:::
:::

## Conditional relative survival {.smaller}

::: columns
::: {.column width="32%"}

::: {.callout-info appearance="simple" icon="false"}
The dashed line represents the 5 and 10-year relative survival after the patients survived for 0, 1, 2, 3, ... years (scale in grey color). 
:::

::: {.callout-note appearance="simple" icon="false"}
We see that in all T-categories, both 5-year and 10-year relative survival condition on surviving certain number of years starts to becomes similar when the conditional year increases.
:::

::: {.callout-note appearance="simple" icon="false"}
For example, two patients diagnosed with T1 and T3 melanoma respectively have similar 5-year relative survival after surviving from 15 years.
:::

:::
::: {.column width="68%"}
![](plots/cond-surv-by-sex-tstage-crn.svg){width="100%"}
:::
:::

## Relative survival trend {.smaller}

::: columns
::: {.column width="32%"}

::: {.callout-info appearance="simple" icon="false"}
The smooth tail in the trend is because of different (hybrid) method used to calculate the relative survival using more recent data. Longer the follow-up loger the smooth tail.
:::

::: {.fragment fragment-index="1"}
::: {.callout-note appearance="simple" icon="false"}
The 5-year, 10-year and 15-year relative survival in all T-categories has stable or slight increasing trend. 
:::

::: {.callout-note appearance="simple" icon="false"}
In the case of thicker melanoma, women have higher increasing trend in T4 melanoma and men have in T3. This pattern is observed in 5-year, 10-year and 15-year follow-up.
:::
:::

:::
::: {.column width="68%"}
::: {.r-stack}
![](plots/trend-by-sex-tstage.svg){width="100%"}

![](plots/trend-by-sex-tstage-llm.svg){.fragment .current-visible fragment-index="1" width="100%"}
:::
:::
:::

#  {.center .middle background-color="#642822"}

::: r-fit-text
Wrap-up
:::

## Outlook {background-image="Images/Drammen-Stasjon.jpg" background-position="right" background-size="auto 100%"}

::: columns
::: {.column width="50%"}
::: {.callout-tip style="min-width: 100%;" icon="false"}
## Upcoming: Incidence and trend
Increasing T1 incidence with plateau around before 2005. Thicker cases are more pronounced in older men.
:::


::: {.callout-note style="min-width: 100%;" icon="false"}
## In progress: Survival and trend
Men have lower survival mainly in thicker cases than women. In thicker cases, more patients die from melnaoma than other cause. 
:::

::: {.callout-warning style="min-width: 100%;" icon="false"}
## Planned: Cut-point analysis
The _cut-points_ are important criteria for _risk assessment_, _diagnosis_ and _follow-up_
:::

:::
:::

## Summary {.ai .dark background-image="Images/AI/Overview-Lake-Boat.jpg" background-position="right" background-size="auto 100%"}

::: columns
::: {.column width="50%" style="font-size: 85%;"}
::: {.callout-note appearance="simple" icon="false"}
-   Despite _stable melanoma mortality_ was seen in cancer reports in Norway for last few years, Norway _ranks second in mortality_ worldwide.
:::
::: {.callout-important appearance="simple" icon="false"}
-   Older men diagnosed more with _thicker melanoma_ and has _higher mortality_
:::

::: {.callout-tip appearance="simple" icon="false"}
-   Awareness focused on *elderly males* may be effective for *early detection*.
-   _Risk stratification_ and _targeted_ screening
:::
:::

::: {.column width="50%"}
:::
:::

# {visibility="hidden"}

##  {#logo-profile .center .smaller}

::: columns
::: {.column width="30%"}
### Collaborators

::: collab-logo
![](Images/Logos/UiO-Logo.png){#uio width="100%"} ![](Images/Logos/CRN-Logo.svg){#crn width="100%"} ![](Images/Logos/QIMR-Logo.png){#qimr width="100%"} ![](Images/Logos/IARC-Logo.png){#iarc width="100%"} ![](Images/Logos/OCBE-Logo.png){#ocbe width="100%"} ![](Images/Logos/OUS-Logo.png){#ous width="100%"} ![](Images/Logos/RNF-Logo.svg){#rnf width="100%"}
:::
:::

::: {.column width="70%"}
### Coauthors

::: profile-container
```{r}
#| results: asis
imgs <- dir("Images/Profile", pattern = "^\\d.*profile.*\\.png", full.names = TRUE)
names(imgs) <- gsub(".*\\/\\d{2}-profile-(.*)\\.png", "\\1", imgs) %>% 
    stringr::str_replace_all("-", " ") %>% 
    stringr::str_to_title()
iwalk(imgs, function(img, name) {
  glue::glue(
    '::: {{.profile-card}}',
    '![]({img}){{width="100%"}}',
    '<p>{name}</p>',
    ':::',
    .sep = "\n"
  ) %>% print()
})
```
:::

::: {style="text-align:center; width:100%; color:firebrick;"}
Funded by: The Research Council of Norway.
:::
:::
:::

##  {background-image="Images/Thank-You.png" background-size="auto 90%"}

## References {.smaller}

::: {#refs}
:::
